Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Mental Health Reinforcement in Wayapi and Teko Communities in French Guiana : Evaluation of the Impact of a Mediation Based Activity in Municipalities of Camopi and Trois Saut in French Guiana (MCS Impact)

2 settembre 2026 aggiornato da: Centre Hospitalier de Cayenne

In French Guiana, Indigenous people experience high levels of psychological distress and higher rates of suicidal behavior than the rest of the population.

The Wayãpi and Teko communities living in Camopi and Trois-Sauts are particularly affected.

Since 2025, Community Workers (CHWs) from these communities have been appointed to facilitate access to care, improve communication between residents and health services, and strengthen support in situations of distress.

To date, no scientific evaluation has been conducted to measure the actual impact of this initiative. This research therefore aims to better understand mental health in these communities and to assess the effect of the community mediators' work.

The results will help improve suicide prevention efforts and adapt public health policies to local realities.

The purpose of this study is to assess the impact of CHWs activities on:

  • suicidal behavior,
  • psychological distress,
  • alcohol use,
  • use of health care services, within the Wayãpi and Teko communities of Camopi and Trois-Sauts.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Descrizione dettagliata

* Rational of the study

The mental health of Indigenous peoples is a major public health and social justice issue. Approximately 370 million Indigenous people live in more than 90 countries, sharing common experiences of historical exclusion, territorial dispossession, and socioeconomic marginalization. These structural determinants result in persistent health inequalities, including suicide rates that are frequently higher than national averages.

International data show significant variability-ranging from 0 to 187.5 suicides per 100,000 people -highlighting the importance of cultural and historical contexts. Ethnicity is not a risk factor in and of itself; vulnerabilities arise from the interaction between historical trauma, socioeconomic conditions, and local cultural dynamics.

The literature highlights three key factors:

  • Structural vulnerability, linked to poverty, discrimination, and limited access to specialized services.
  • Historical and intergenerational trauma linked to colonization, forced displacement, and assimilation policies, which contribute to mental health disorders.
  • Resources for resilience: cultural continuity, local governance, and strong kinship networks.

International comparisons confirm that communities with territorial control, autonomous institutions, or adapted educational systems have significantly lower suicide rates.

The Amazon is a region particularly affected by inequalities in Indigenous mental health. Despite remarkable linguistic and cultural diversity, the region remains marked by the legacy of colonization, resource exploitation, missionary activity, and a chronic lack of health and educational infrastructure.

Available data indicate that suicide rates reach particularly high levels in several Amazonian contexts: up to twenty times the national average among the Guarani-Kaiowá in Brazil, 247.9 per 100,000 inhabitants among the Emberá Dobidá in Colombia, and rates higher than the national average in the Ecuadorian Amazon. These situations reflect the cumulative effect of structural, social, and historical vulnerabilities, the manifestation of which varies according to national and local contexts.

Although it is a department of a high-income country, French Guiana exhibits health inequalities comparable to those observed in low-resource settings. The Amazonian interior, accessible only by canoe or plane, suffers from significant geographic isolation, limiting access to specialized care.

In French Guiana, the municipality of Camopi, which includes the village of Trois-Sauts, has particularly high suicide rates, estimated at 113 and 137 per 100,000 inhabitants, respectively, with suicide attempt rates approaching 400 per 100,000 inhabitants. Suicides primarily affect young people aged 10 to 29, who account for more than 60% of suicide deaths, with an average age of 25 in the interior compared to 36 on the coast.

The observed vulnerabilities result from a complex interplay of factors: alcohol abuse and substance use disorders, domestic violence, a loss of identity due to rapid sociocultural changes, as well as the social and environmental impacts of illegal gold mining. These factors interact within a context of severe social precariousness and the erosion of community structures.

The concentration of psychiatric services in the prefecture and main French Guina town, Cayenne, the language barrier (with Wayãpi and Teko being the predominant languages), and the lack of interventions that are sustainably adapted to Indigenous contexts hinder the effectiveness of existing systems, exacerbating inequalities in access to and care for mental health.

Beyond socioeconomic and health determinants, the situations of psychological distress observed in Wayãpi and Teko communities are embedded in culturally situated frameworks of understanding. Representations of psychological distress, illness, and suicide are inseparable from a relational worldview in which bodily, social, territorial, and symbolic dimensions are closely intertwined.

In this context, psychological distress is not viewed exclusively as an individual disorder, but as an imbalance affecting the relationships between the individual, their social environment, and the symbolic frameworks mobilized to make sense of their lived experience. The failure to take these interpretive frameworks into account in healthcare systems constitutes an additional factor contributing to underutilization of services and the ineffectiveness of interventions.

In many countries, community health workers (CHWs) are a key lever for reducing health inequalities. Their cultural proximity facilitates early detection of health issues, language mediation, psychosocial support, and adherence to care.

In French Guiana, six Wayãpi and Teko Community Health Workers (CHWs) were deployed in 2025 in the municipalities of Camopi and Trois-Sauts. They serve as a bridge between so-called "traditional" medicine and allopathic medicine, facilitating access to care and the management of distressing situations.

Despite these advances, several gaps remain:

  • A lack of standardized epidemiological data on the mental health of the Wayãpi and Teko peoples, aside from suicide mortality.
  • Limited qualitative documentation, particularly regarding perceptions of suffering, addiction, and suicide.
  • A complete lack of scientific evaluation of the role and impact of CHWs in French Guiana. Their effectiveness is assumed by analogy with the Brazilian model but has never been empirically verified.

These gaps hinder the development of appropriate prevention policies and keep the communities' real needs hidden. Three key findings emerge:

  1. Indigenous peoples are disproportionately vulnerable to suicide, with significant variations depending on context.
  2. The Amazon, and French Guiana in particular, is an area with a very high incidence of suicide.
  3. CHWs represent a promising avenue, but require rigorous scientific evaluation.

    • Hypothesis of the study

      • The cultural and linguistic background of the CHWs, who come from the Wayãpi and Teko communities, fosters trust, improves communication, and facilitates access to care, thereby contributing to a reduction in suicidal behaviors.
      • The integration of cultural representations and traditional practices (Tupi-Guarani worldview, rituals, and symbols of suffering) into mediation strengthens individual and collective resilience in the face of mental health disorders.
      • The community mediation model, inspired by the Brazilian Agentes Indígenas de Saúde, is transferable and effective in French Guiana, provided it is adapted to local social, linguistic, and territorial specificities.
      • The close ties between CHWs and their communities are an essential resource for the early detection of crises, but can also lead to emotional overload, requiring appropriate supervision and support.
      • The introduction of CHWs has a measurable positive effect on social cohesion by strengthening community ties, reducing stigma, and facilitating the integration of biomedical care with traditional knowledge.
    • Design of the study

This is a single-center, quasi-experimental, prospective before-and-after study conducted in the municipality of Camopi (including Trois-Sauts).

  • Retrospective phase: analysis of the 5 years preceding the introduction of MCS (aggregated data from institutional records).
  • Inclusion: random selection of participants by drawing households at random from a georeferenced aerial map.
  • Prospective phase: individual longitudinal follow-up over 30 months.
  • Repeated assessments: M0, M12, M24, M30.
  • Mixed-methods approach: standardized quantitative questionnaires (K10, AUDIT-C, WHO SUPRE-MISS/CIDI suicide module) and qualitative investigations (interviews, focus groups).

    * Objectives of the study

  • Primary Objective To evaluate the effectiveness of the CHWs intervention in preventing suicide and reducing suicidal behaviors among the Wayãpi and Teko populations of Camopi and Trois-Sauts.
  • Secondary Objectives

The secondary objectives aim to document the mechanisms, cultural dimensions, and social effects associated with the CHWs' intervention:

  1. Estimate the prevalence of psychological distress and alcohol use among the Wayãpi and Teko communities.
  2. Estimate the use of psychiatric health care services.
  3. Describe cultural representations of distress, suffering, and suicide, as well as the relational and cosmological dynamics mobilized to account for them.
  4. Analyze the role of CHWs as an intercultural interface by documenting how they integrate traditional practices with biomedical care.
  5. Assess the perceived impact of CHWs on social cohesion, the reduction of stigma, and the strengthening of community support resources.
  6. Identify the needs, limitations, working conditions, and burnout factors among CHWs, in order to evaluate the feasibility, sustainability, and conditions for the effectiveness of the program.

    • Benefits

The expected benefits apply to communities, health institutions, and scientific knowledge alike.

For the Wayãpi and Teko communities:

  • improved access to care and early detection of distress
  • reduction of stigma related to mental health
  • strengthening of social cohesion and the integration of traditional healing with biomedicine.

For institutional stakeholders:

  • unprecedented epidemiological data enabling the adaptation of suicide prevention strategies
  • support for the implementation of a structured model of intercultural intervention based on the work of the CHWs
  • improved training for professionals on intercultural approaches.

For research:

  • generation of the first quantitative and qualitative data on the mental health of the Wayãpi and Teko
  • development of a methodological framework that can be applied in other Amazonian context

Tipo di studio

Osservativo

Iscrizione (Stimato)

300

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Cassio De Figueiredo Azze, MCs
  • Numero di telefono: +33594395050
  • Email: cassiofr@gmail.com

Luoghi di studio

    • French Guiana
      • Cayenne, French Guiana, Guiana francese, 97300
        • Centre Hospitalier de Cayenne
        • Contatto:
          • Cassio De Figueiredo Azze, MSc
          • Numero di telefono: +33594395050
          • Email: cassiofr@gmail.com
        • Contatto:
        • Investigatore principale:
          • Cassio De Figueiredo Azze, MCs

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Adults and children over 12 years of age from the Wayapi and Teko communities in the villages of Camopi and Trois-Saut in French Guiana

Descrizione

Inclusion Criteria:

  • Age > 12 years
  • Members of the Wayãpi or Teko communities residing in Camopi or Trois-Sauts.
  • No objection to participating in the study and to the use of their data after receiving information in local languages and in French

Exclusion Criteria:

  • Individuals under legal guardianship
  • Health conditions that prevent them from understanding or completing questionnaires or participating in interviews.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in the incidence of suicidal behaviours (suicidal ideation, suicide attempts, and suicide deaths) in the villages of Camopi and Trois-Sauts before and after the deployment of CHWs
Lasso di tempo: From inclusion to 12, 24 and 30 months after CHWs intervention
Change in the incidence of suicidal behaviours (suicidal ideation, suicide attempts, and suicide deaths) in the study population, comparing retrospective suicidal behaviour rates in the 5 years before with propective suicidal behaviour rates at 12, 24 and 30 months after the intervention of CHWs among the study population
From inclusion to 12, 24 and 30 months after CHWs intervention

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Prevalence of psychological distres
Lasso di tempo: From inclusion to 12, 24 and 30 months
Measurement of psychological distress score using the validated K10 scale
From inclusion to 12, 24 and 30 months
Prevalence of alcohol use pattern
Lasso di tempo: From inclusion to 12, 24 and 30 months
Measurement of alcohol use pattern using the validated AUDIT-C scale
From inclusion to 12, 24 and 30 months
Health-care utilisation
Lasso di tempo: From inclusion to 12, 24 and 30 months
Number of out patient visits and hospitalisations in psychiatric and general medical services
From inclusion to 12, 24 and 30 months
Cultural representations of mental health and CHWs intervention
Lasso di tempo: From inclusion to 12, 24 and 30 months
Analysis of the cultural representations of mental health and CHWs intervention using a qualitative questionnaire with individuals and focus group strategy with groups of participants
From inclusion to 12, 24 and 30 months
Community perceptions of mental health and of CHWs intervention
Lasso di tempo: From inclusion to 12, 24 and 30 months
Analysis of the community perceptions of mental health and CHWs intervention using a qualitative questionnaire with individuals and focus group strategy with groups of participants
From inclusion to 12, 24 and 30 months
Social cohesion and community resilience indicators
Lasso di tempo: From inclusion to 12, 24 and 30 months
Measurement of the community solidarity and perception of community stigma using individual qualitative questionnaires and focus group strategies
From inclusion to 12, 24 and 30 months
Management needs of CHWs
Lasso di tempo: At 12, 24 and 30 months
Measurement of the level of management and support needed by CHWs in their activities using qualitative questionnaires
At 12, 24 and 30 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Direttore dello studio: Mathieu Nacher, MD, PhD, Centre Hospitalier de Cayenne, Inserm CIC 1424 Guyane-Amazonie

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

30 agosto 2029

Completamento dello studio (Stimato)

30 agosto 2029

Date di iscrizione allo studio

Primo inviato

2 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

2 settembre 2026

Primo Inserito (Effettivo)

9 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

9 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 settembre 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • MCS Impact

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

Only aggregated data will be shared

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .